Topical & Transdermal CDMOs

Apace Packaging LLC

United States

Apace Packaging is a U.S.-based FDA-registered contract pharmaceutical packaging and manufacturing company. They specialize in pharmaceutical packaging (blistering, bottling, tube filling, sachet packaging, clinical trial packaging) and also perform liquid and semi-solid manufacturing (blending, tube filling). They are DEA-licensed for Schedule II-V controlled substances.

Aphena Pharma Solutions

United States

Aphena Pharma Solutions is a U.S.-based contract pharmaceutical manufacturing and packaging company operating from two FDA-registered locations. They specialize in liquid dose manufacturing, oral solid dose packaging, blister packaging, bottling, tube filling, injectable assembly, and clinical packaging. They are DEA-licensed for Schedule II-V controlled substances and ISO 13485 certified for medical devices.

Applied Laboratories, Inc.

United States

Applied Laboratories, Inc. is a cGMP contract manufacturer headquartered in Columbus, Indiana, specializing in liquids, semi-solids (creams, ointments, gels), and topical pharmaceutical products. Originally founded in 1984 as an FDA regulatory consulting firm, it evolved into a full-service contract manufacturer with 200,000 sq-ft of cGMP facilities registered for both drug and medical device production. They provide formulation development through commercial-scale manufacturing, filling, labeling, and packaging for OTC pharmaceuticals and healthcare products.

Cipla

China

Cipla is a major Indian multinational pharmaceutical company that manufactures and markets its own branded generic medicines globally. While Cipla has formed joint ventures with CDMOs like Kemwell Biopharma for biosimilar development, the company itself is a pharmaceutical manufacturer selling its own products, not a contract manufacturer for others.

Delpharm

Canada

Delpharm is one of the world's top five CDMOs, specializing in the development and manufacture of medicines across solid, sterile, semi-solid, and liquid dosage forms with particular expertise in nasal sprays and injectables. The company operates 18 manufacturing sites and 3 development centers across Europe and North America, with 6,500 employees and over 1.1 billion EUR in turnover. Delpharm produces over 650 million units annually and recently received a $60 million Canadian government investment to modernize its Boucherville injectable facility.

DifGen Pharmaceuticals

United States

DifGen Pharmaceuticals is a US-based CDMO specializing in complex generics and advanced drug delivery systems, providing end-to-end solutions from product development through commercial manufacturing. Through its 2023 acquisition of Aveva Drug Delivery Systems Inc., DifGen gained a 455,000 sq. ft. US manufacturing footprint producing over 300 million transdermal patches annually, including controlled substances like buprenorphine transdermal systems.

Glenmark (incl. API arm Glenmark Life Sciences)

Argentina

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company focused on branded and generic formulations, with an API manufacturing arm called Glenmark Life Sciences. The company manufactures APIs and finished dosage forms primarily for its own portfolio, spanning dermatology, respiratory, oncology, and cardiovascular therapeutic areas. Glenmark Life Sciences produces over 120 APIs across multiple manufacturing sites in India.

Helba İlaç İç ve Dış San. Tic. A.Ş.

Turkey

Helba Pharma is a Turkish pharmaceutical manufacturer established in 2008, with roots in Welfar Pharma founded in Azerbaijan in 1995. The company produces solid and semi-solid form medicines at its GMP-certified production facility with 50 million box manufacturing capacity, and actively exports to CIS countries, Balkans, and Middle Eastern markets.

Hovid Bhd

Malaysia

Hovid Bhd is a Malaysia-based pharmaceutical company with over 80 years of history, operating as both a branded generic producer and contract manufacturer. The company offers a portfolio of over 400 products including generic drugs, OTC supplements, disinfectant solutions, medical devices, and consumer products, with distribution in more than 50 countries.

Importfab Inc

Canada

Importfab Inc (now Labomar Canada) is a well-established Canadian contract manufacturer acquired by Labomar S.p.A., a leading Italian CDMO. The company specializes in manufacturing pharmaceuticals, natural health products, cosmetics, nutraceuticals, and veterinary products. It recently completed an FDA audit and expanded its headquarters facility in Montreal.

Lannett CDMO

United States

Lannett CDMO is the contract development and manufacturing arm of Lannett Company, a generic pharmaceuticals company. Specializes in oral solid dose (OSD) and liquid formulations, including high-potency compounds and DEA-controlled substances. Operates a 425,000 sq ft cGMP-certified manufacturing facility in Seymour, Indiana with dedicated suites for potent drugs. Capabilities include technology transfers, modified release technology, complex formulations, and reformulation. Has over 100 product families currently in distribution. Acquired by Aurobindo Pharma USA Inc. for $250 million in July 2025. Revenue of $306 million in FY 2025.

Lichtenheldt GmbH

Germany

Lichtenheldt GmbH is a German pharmaceutical contract manufacturer (CDMO) specializing in non-sterile liquid and semi-solid dosage forms since 1745. The company produces prescription drugs (Rx), OTC products, homeopathic medicines, disinfectants, dietary supplements, and cosmetics. It serves over 50 customers from small to large pharmaceutical companies.

Losan Pharma GmbH

Germany

Losan Pharma GmbH is a German full-service CDMO with 30 years of experience in the development and manufacturing of medicinal products, including solids, semi-solids, and liquids. The company's products are distributed in over 70 countries. Losan Pharma has been successfully inspected by the US FDA, ANVISA (Brazil), Saudi FDA, and Turkish authorities. The company specializes in improving API performance through enhanced bioavailability, stability, and customized release profiles.

NextPharma

Finland

NextPharma is a European pharmaceutical CDMO headquartered in Finland with 10 manufacturing sites across Europe. The company provides pharmaceutical development, clinical trial supply, commercial manufacturing, packaging, and analytical services across a wide range of dosage forms including solids, semi-solids, liquids, softgel capsules, ophthalmics, modified release products, and specialist areas such as hormones, cephalosporins, penicillins, and narcotics.

O.F.I. Officina Farmaceutica Italiana

Italy

O.F.I. Officina Farmaceutica Italiana is an Italian contract development and manufacturing company established in 1946, specializing in food supplements, medical devices, and dermo-cosmetic products. The company provides full-service contract manufacturing from idea generation to production, with capabilities in tablets, capsules, creams, gels, probiotics, and sterile processes. OFI holds ISO certifications including ISO 13485 (medical devices) and is FDA approved and Halal certified.

Pharmaghreb

Tunisia

Pharmaghreb is the first private pharmaceutical industry created in Tunisia, founded in 1985. The company manufactures pharmaceutical products including tablets, creams, gels, and parapharmaceutical products. It holds ISO 9001:2015 and ISO 14001:2015 certifications and has expanded internationally. In 2024, BioGeneric Pharma acquired a majority stake in Pharmaghreb.

Praxis Packaging Solutions

United States

Praxis Packaging Solutions is a U.S.-based contract packaging company in Grand Rapids, Michigan, providing primary and secondary packaging services for pharmaceutical, OTC, and healthcare products. Their capabilities include solid dose packaging (bottling, blister packaging), liquid/cream/paste filling for tubes, bottles, jars, and flexible packaging, and secondary packaging (labeling, cartoning, bundling, kitting). They operate FDA-registered, DEA-licensed (Schedule III-V), and cGMP-compliant facilities. FDA-registered with 2 FEI numbers with 4 inspections (3 NAI, 1 VAI). While primarily a packager, they perform contract manufacturing for finished dosage forms.

Renejix Pharma Solutions

United States

Renejix Pharma Solutions (operating as HyCON Labs) is a US-based CDMO specializing in small molecule oral dosage form development and multi-modality manufacturing. The company offers end-to-end services from preformulation through commercial manufacturing, with 14+ technologies, 300+ pieces of equipment, 350+ employees, and 2+ facilities. They serve as a single-partner CDMO across all development stages.

Sandoz

Austria

Sandoz is a global leader in generic and biosimilar medicines, spun off from Novartis in 2023 as a standalone company. It manufactures and markets generic pharmaceuticals and biosimilars but operates as a branded pharmaceutical company, not a contract manufacturer for third parties.

SIDEFARMA

Portugal

SIDEFARMA is a Portuguese CMO with over 45 years of experience, specialized in the manufacture of small and medium-size batches of solid dosage forms (coated tablets, tablets, capsules), semi-solids (creams, gels, ointments), and liquid pharmaceuticals. The company provides contract manufacturing, contract packaging, and contract development services following European quality standards, while also commercializing its own branded pharmaceutical products.

Srikem Laboratories Pvt Ltd

India

Srikem Laboratories Pvt Ltd is an Indian pharmaceutical company based in Navi Mumbai (MIDC Taloja industrial area) that manufactures active pharmaceutical ingredients. Search results indicate they supply APIs including Clotrimazole and antibacterials for systemic use. No website text was available. They are listed on PharmaSource and appear in a Global Business Reports feature on India Pharmaceuticals as investing in R&D and manufacturing capabilities. Limited information prevents a more detailed classification, but evidence points to API manufacturing rather than contract drug product manufacturing.

Titan Laboratories Pvt Ltd

India

Titan Laboratories Pvt Ltd is an integrated Indian pharmaceutical company and the first Indian pellet company to receive EU-GMP Written Confirmation. Established in 2004, it manufactures and exports pharmaceuticals and APIs across 47 countries, with specialization in pellets, granules, tablets, capsules, and creams/ointments. The company holds EU-GMP, TGA, ANVISA, WHO-GMP, MFDS, and other international approvals.

Tosca Pharmachem (Tosco Pharmachem Pvt Ltd)

India

Tosco Pharmachem Pvt Ltd is an Indian pharmaceutical contract manufacturing company providing third-party/contract manufacturing services for formulated pharmaceutical products. The company's website has been compromised by spam, but search results confirm it operates as a CMO offering pharmaceutical manufacturing across multiple dosage forms including tablets, capsules, liquids, and topicals.

Vefa İlaç San. ve Tic. A.Ş.

Turkey

Vefa Ilac San. ve Tic. A.S. is a Turkish pharmaceutical manufacturer based in Beylikduzu, Istanbul, established in 2012 with GMP certification obtained in 2013. They manufacture pharmaceuticals, traditional herbal medicines, food supplements, and personal care products for both domestic and export markets. They have significant production capacity: 902 million tablets/year, 270 million capsules/year, 252 million coated units/year, 48 million bottles/year, and 15 million cream & gel units/year. Products are exported to Azerbaijan, Georgia, Ukraine, Iraq, Yemen, Saudi Arabia, and Romania. They hold WHO GMP and ISO 9001:2015 certifications. Their vision focuses on becoming a leading private label (contract) production base in Eurasia for pharmaceutical and nutraceutical products.

Vianex S.A.

Greece

Vianex S.A. is a prominent Greek pharmaceutical company listed on PharmaSource as a CDMO. The company is described as specializing in contract development and manufacturing. While the website content is primarily in Greek and could not be fully parsed, PharmaSource confirms CDMO services. The company appears to have multiple manufacturing facilities (Factory A, B, C, D mentioned in navigation) and covers a broad range of dosage forms. Founded by Paul J. Giannacopoulos.

Bionex Pharmaceuticals LLC is a US-based pharmaceutical development CRMO (Contract Research and Manufacturing Organization) specializing in novel topical, transdermal/transmucosal, and implant drug delivery systems. They offer pre-formulation through clinical supply manufacturing, with many R&D projects funded by NIH and NSF grants. Located at the New Jersey Bioscience Center. They have had 3 FDA recalls (1 Class I, 2 Class II).

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

IDI Integratori Dietetici Italiani srl is an Italian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products, dietary supplements, and medical devices. The company has FDA-registered facilities and produces a range of products including tablets, creams, oral solutions, and injectable formulations across multiple therapeutic areas.

International Drug Development Institute(IDDI)

Belgium

IDDI (International Drug Development Institute) is a clinical data science CRO specializing in biostatistics, clinical data management, strategic consulting, and eClinical technologies. Founded in 1991, the company has completed over 1,500 clinical trials for 350+ clients, with 80% repeat business. IDDI's therapeutic focus is oncology and ophthalmology, representing 75% of their work.

Lee Pharma Limited

India

Lee Pharma Limited is an Indian pharmaceutical company established in 1997 in Hyderabad, focused on the development, synthesis, and commercialization of Active Pharmaceutical Ingredients (APIs), intermediates, semi-finished dosage forms (pellets and granules), and finished formulations. Manufacturing facilities are approved by USFDA, EUGMP, and WHO GMP. Listed on CPHI Online as a CMO/CDMO and manufacturer. Serves partners in 30+ countries with a focus on Europe and Asia. Also has a CDMO services page and offers contract manufacturing services.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Swiss American CDMO is a contract development and manufacturing organization headquartered in Carrollton, Texas, specializing in topical skin care, sun care, and wound care products. The company operates a 134,200 sq. ft. cGMP facility and a second 131,070 sq. ft. facility in the Dallas Metroplex. With over 35 years of experience, they develop, manufacture, package, and commercialize topical drug, skincare, wound care, and medical device formulations.

Taiwanese CDMO specializing in transdermal drug delivery systems (TDDS), topical patches, and oral films. Over 30 years of experience in hydrogel patch, NSAID patch, and cosmetic patch development and manufacturing. Covers over 70% of OTC patches on the Taiwan market and exports to Asia, Europe, and North America. Also offers CMO and CRO services for transdermal patch development.

US-based topical and transdermal pharmaceutical CDMO, now merged with MedPharm (Durham, NC). Provides end-to-end services from formulation development through commercial manufacturing for topical, transmucosal, and transdermal drug products. Specializes in semi-solids, aerosols, liquids, injections, and transdermal patches. Offers in-vitro permeation testing (IVPT), in-vitro release testing (IVRT), disease activity models, tissue protein binding, and continuous flow technologies. GMP-certified manufacturing for generics, OTC, and prescription products.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.

OLIC (Thailand) Limited is one of the largest toll and contract manufacturers in Southeast Asia for branded pharmaceutical and healthcare products. The company is a subsidiary of Fuji Pharma and serves over 30 multinational companies including most Big Pharma organizations. OLIC's PIC/S-compliant manufacturing facility produces a wide range of dosage forms including sterile liquids, oral solids, semi-solids, and liquids, serving markets in Thailand, Southeast Asia, Japan, Australia, the US, and Europe.

Tirupati Group is one of India's largest contract development and manufacturing organizations (CDMOs), providing end-to-end solutions across pharmaceuticals, nutraceuticals, Ayurveda, and sports nutrition. Founded in 2005, the company operates state-of-the-art manufacturing facilities in Paonta Sahib (Himachal Pradesh) and Noida (Uttar Pradesh), serving 350+ clients including Abbott, Pfizer, Dr. Reddy's, and Sun Pharma.

Corning Incorporated (Life Sciences & Pharmaceutical Technologies)

India

Corning Incorporated's Pharmaceutical Technologies division manufactures advanced glass packaging solutions for the pharmaceutical industry, most notably Valor Glass vials and containers designed for drug storage and delivery. The company is a materials science and glass technology company, not a drug manufacturer or CDMO.

Laboratoires Théa

France

Laboratoires Thea is an independent French pharmaceutical company based in Clermont-Ferrand, 100% dedicated to ophthalmology. They are Europe's leading independent eye-care group, specializing in researching, developing, manufacturing, and commercializing ophthalmic products including preservative-free eye drops and drug delivery systems for glaucoma, dry eye, allergies, infections, inflammation, and retinal disorders. They are present in 70+ countries and have partnerships with companies like LENZ Therapeutics, Novaliq, and ProQR. While they manufacture their own products, they are a branded pharmaceutical company, not a CDMO or contract manufacturer.

Solventum

China

Solventum (spun off from 3M) is a healthcare company whose Purification and Filtration business provided biopharmaceutical purification solutions including chromatography media, filtration membranes, and purification systems. This business unit has been acquired by Thermo Fisher Scientific. Solventum supplied equipment and consumables for bioprocessing, not contract drug manufacturing.

SteriMax Inc.

Canada

SteriMax Inc. is a family-owned Canadian specialty pharmaceutical company based in Oakville, Ontario. They develop, source, manufacture, market, and distribute essential hospital and retail pharmacy products to the Canadian healthcare market. Their portfolio includes generic and branded products across sterile injectables, oral solids, and other essential products. SteriMax has a Health Canada-approved QC lab and their products are manufactured in Health Canada, FDA, or EMEA approved facilities. While they have some internal pharmaceutical manufacturing capabilities (their website mentions production and manufacturing), their primary model appears to be sourcing, marketing, and distributing pharmaceutical products in Canada rather than offering contract manufacturing services to third parties. They are not positioned as a CDMO/CMO.

CMP Phar.ma Srl

Italy

CMP Phar.ma Srl is an Italian manufacturer of inspection and leak test machines for pharmaceutical parenteral products, operating since 1969. The company produces optical inspection benches, semi-automatic and fully automatic inspection machines, and leak test systems for ampoules, vials, cartridges, and prefilled syringes, with ISO 9001 certification since 2008. CMP Phar.ma is part of the Marchesini Group.

Eumedica Pharmaceuticals

Belgium

Eumedica Pharmaceuticals is a Belgian pharmaceutical distribution and logistics company operating since 1986, providing warehousing, value-added logistics services, secondary packaging, serialization, and regulatory affairs for multinational pharmaceutical companies. It distributes pharmaceutical products but does not manufacture drugs under contract for others.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is one of the world's largest specialty generic pharmaceutical companies, headquartered in Mumbai, India. While the company has massive manufacturing operations (1,075 FDA-approved products, 25+ FDA-registered FEI numbers), it primarily manufactures and markets its own branded and generic pharmaceutical products rather than providing contract manufacturing services to third parties as a CDMO.

Hoffmann Neopac AG is a leading packaging manufacturer of Polyfoil, PE, and COEX tubes for pharmaceutical, cosmetics, and dental industries with over 100 years of history. The company operates production sites in Switzerland (450 million tubes/year), Hungary, the US, and India, with combined global capacity exceeding 1 billion tubes per year. Neopac is ISO 15378 (pharmaceutical packaging) certified but does not manufacture drugs.